[go: up one dir, main page]

CA2018794A1 - Sels d'addition acides de cephem cristallins et procede de preparation - Google Patents

Sels d'addition acides de cephem cristallins et procede de preparation

Info

Publication number
CA2018794A1
CA2018794A1 CA2018794A CA2018794A CA2018794A1 CA 2018794 A1 CA2018794 A1 CA 2018794A1 CA 2018794 A CA2018794 A CA 2018794A CA 2018794 A CA2018794 A CA 2018794A CA 2018794 A1 CA2018794 A1 CA 2018794A1
Authority
CA
Canada
Prior art keywords
processes
preparation
acid addition
addition salts
cephem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2018794A
Other languages
English (en)
Other versions
CA2018794C (fr
Inventor
Friedhelm Adam
Walter Durckheimer
Burkhard Mencke
Dieter Isert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of CA2018794A1 publication Critical patent/CA2018794A1/fr
Application granted granted Critical
Publication of CA2018794C publication Critical patent/CA2018794C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002018794A 1989-06-13 1990-06-12 Sels d'addition acides de cephem cristallins et procede de preparation Expired - Lifetime CA2018794C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3919259A DE3919259A1 (de) 1989-06-13 1989-06-13 Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DEP3919259.8 1989-06-13

Publications (2)

Publication Number Publication Date
CA2018794A1 true CA2018794A1 (fr) 1990-12-13
CA2018794C CA2018794C (fr) 2000-05-16

Family

ID=6382651

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002018794A Expired - Lifetime CA2018794C (fr) 1989-06-13 1990-06-12 Sels d'addition acides de cephem cristallins et procede de preparation

Country Status (19)

Country Link
US (1) US5409918A (fr)
EP (1) EP0402806B1 (fr)
JP (1) JPH0730085B2 (fr)
KR (1) KR0158883B1 (fr)
CN (1) CN1043043C (fr)
AT (1) ATE95185T1 (fr)
AU (1) AU645254B2 (fr)
CA (1) CA2018794C (fr)
DE (2) DE3919259A1 (fr)
DK (1) DK0402806T3 (fr)
ES (1) ES2045653T3 (fr)
FI (1) FI96424C (fr)
HU (1) HU207087B (fr)
IE (1) IE64076B1 (fr)
IL (1) IL94701A (fr)
NO (1) NO174258C (fr)
NZ (1) NZ234004A (fr)
PT (1) PT94347B (fr)
ZA (1) ZA904526B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842791B2 (en) 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU48484B (sh) * 1991-05-24 1998-09-18 Hoechst Aktiengesellschaft Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline
US5589593A (en) * 1991-11-11 1996-12-31 Biochimica Opos Spa Crystalline form of a cephalosporin antibiotic
TW212181B (fr) * 1992-02-14 1993-09-01 Hoechst Ag
EP0570849B1 (fr) * 1992-05-21 1998-03-25 Hoechst Aktiengesellschaft Procédé de clivage de prodrug esters de céphalosporine en 7-amino-3-méthoxyméthylcéph-3-èm-4-carboxylique
LT3871B (en) 1993-11-30 1996-04-25 Hoechst Ag Additive crystalline salts of pure diastereomers of 1-cefem-4-carboxylic acid 1-(2,2-dimethyl-propionyloxy)ethyl esters, process for the preparation thereof, pharmaceutical compositions and process for the preparation thereof
AT401651B (de) * 1994-06-14 1996-11-25 Biochemie Gmbh 7-(2-(2-aminothiazol-4-yl)-2-(z)- hydroximinoacetamido)-3-n,n- dimethylcarbamoyloxymethyl-3-cephem-4-
AT408226B (de) * 1999-05-05 2001-09-25 Biochemie Gmbh Kristalliner 7-(2-(2-formylaminothiazol-4-yl)-2
JP4749194B2 (ja) * 2006-03-28 2011-08-17 ジャパンパイル株式会社 オーガー削孔装置における土質試料採取具

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668783A (en) * 1974-12-19 1987-05-26 Takeda Chemical Industries, Ltd. Thiazolylacetamido cephalosporin compounds
US4298606A (en) * 1974-12-19 1981-11-03 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
JPS5760345B2 (fr) * 1974-12-19 1982-12-18 Takeda Chemical Industries Ltd
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4203899A (en) * 1974-12-19 1980-05-20 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
JPS523091A (en) * 1975-06-23 1977-01-11 Takeda Chem Ind Ltd A prcess for preparing cephalosporins
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
JPS6011713B2 (ja) * 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
IT1101437B (it) * 1978-11-28 1985-09-28 Proter Spa Procedimento per il recupero di cefaloridina da soluzione acquosa nella quale e'stata prodotta
US4409215A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical Co., Ltd. 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof
FR2476087A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
US4486425A (en) * 1980-09-30 1984-12-04 Sankyo Company Limited 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
JPS5759894A (en) * 1980-09-30 1982-04-10 Sankyo Co Ltd Cephalosporin for oral administration
FR2532315A1 (fr) * 1982-08-27 1984-03-02 Rhone Poulenc Sante Formes cristallisees de sels d'addition avec des acides, de l'((amino-2-thiazolyl-4)-2 methoxyimino-2 acetamido)-7 carboxy-2 (dioxo-5,6 formylmethyl-4 tetrahydro-1,4,5,6 triazine-1,2,4 yl-3) thio-2 vinyl)-3 oxo-8 thia-5 aza-1 bicyclo(4.2.0) octene-2 isomere syn, forme e et leur preparation
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
DE3809561A1 (de) * 1988-03-22 1989-10-05 Hoechst Ag Ester der 7-(2-(2-aminothiazol-4-yl)-2-(z)- hydroxyiminoacetamido)-3-methoxymethyl-3-cephem-4-carbonsaeure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842791B2 (en) 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions

Also Published As

Publication number Publication date
NZ234004A (en) 1992-07-28
CN1048042A (zh) 1990-12-26
AU5697690A (en) 1990-12-20
IE902115L (en) 1990-12-13
AU645254B2 (en) 1994-01-13
EP0402806B1 (fr) 1993-09-29
FI902900A0 (fi) 1990-06-11
JPH0730085B2 (ja) 1995-04-05
DE59002880D1 (de) 1993-11-04
ZA904526B (en) 1991-03-27
ES2045653T3 (es) 1994-01-16
FI96424C (fi) 1996-06-25
NO174258C (no) 1994-04-06
PT94347B (pt) 1997-01-31
NO902607L (no) 1990-12-14
IL94701A (en) 1994-11-28
ATE95185T1 (de) 1993-10-15
DK0402806T3 (da) 1994-01-17
IE64076B1 (en) 1995-07-12
KR0158883B1 (ko) 1998-12-01
DE3919259A1 (de) 1990-12-20
IE902115A1 (en) 1991-01-02
HU207087B (en) 1993-03-01
PT94347A (pt) 1991-02-08
HUT56375A (en) 1991-08-28
IL94701A0 (en) 1991-04-15
NO902607D0 (no) 1990-06-12
NO174258B (no) 1993-12-27
JPH0324086A (ja) 1991-02-01
EP0402806A1 (fr) 1990-12-19
US5409918A (en) 1995-04-25
CN1043043C (zh) 1999-04-21
HU903828D0 (en) 1990-11-28
KR910000748A (ko) 1991-01-30
FI96424B (fi) 1996-03-15
CA2018794C (fr) 2000-05-16

Similar Documents

Publication Publication Date Title
CA2103838A1 (fr) 7-(substituant)-8-(substituant)-9-[(glycyle substitue)amido]-6-demethyl-6-desoxytetracyclines
AU565927B2 (en) Cephalosporin derivatives
AU555444B2 (en) Cephalosporin derivatives
CA2018794A1 (fr) Sels d'addition acides de cephem cristallins et procede de preparation
GR3031542T3 (en) Cephalosporinderivatives and process for its preparation
IE880503L (en) Crystallized cephem-acid addition salts, and a process for the preparation thereof
CA2219311A1 (fr) Derives de 10,13,15-trioxatricyclo[9.2.1.1.9.6]pentadecanone, methode de preparation et compositions pharmaceutiques a base de ces derives
CA2028514A1 (fr) Traitement de la depression
CA2045761A1 (fr) Monosulfate ou disulfate ws7622a; methode de preparation et utilisation
ES2002903A6 (es) Procedimiento para preparar derivados de cefalosporina
CA2013226A1 (fr) Derives de cephalosporine et procede de preparation
CA2029785A1 (fr) Derives d'acide glutarique et mode de preparation
CA2030421A1 (fr) Agent pour le traitement des contractions cerebrovasculaires
CA2048355A1 (fr) Derives de l'acide p-oxybenzoique, procede pour sa preparation et son utilisation comme medicament
EP0281092A3 (fr) Dérivés de céphalosporine et procédé pour leur préparation
CA2204527A1 (fr) Acides 2,2-dichloroalcanecarboxyliques, leur procede de preparation, medicaments les contenant, et leur utilisation dans le traitement de la resistance insulinique

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry